CLNT [Cleantech Solutions International,] 8-K: China Wind Systems, Reports Second Quarter 2010 Results

[China Wind Systems, Reports Second Quarter 2010 Results -- Second quarter 2010 revenuesreased 39.7% to $19.0 million -- Netomereased 69.8% to $3.0 million, or $0.12 per diluted share Press Release CWS News WUXI, Jiangsu, China, Aug. 16 /PRNewswire-Asia-FirstCall/ -- China Wind Systems, (Nasdaq: Second Quarter 2010 Highlights and Recent Events]

LONG [eLong,] 6-K: (Original Filing)

[99.1 Press Release issued by the Company on August 16, 2010: “eLong Reports Second Quarter 2010 Unaudited Financial Results” DATED: August 17, 2010 ELONG, INC Mike Doyle Chief Financial Officer eLong Reports Second Quarter 2010 Unaudited Financial Results BEIJING, China — August 16, 2010 — eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited]

By | 2016-03-02T12:23:11+00:00 August 17th, 2010|Categories: Chinese Stocks, LONG, SEC Original|Tags: , , , , , |0 Comments

LONG [eLong,] 6-K: 99.1 Press Release issued by the Company on

[99.1 Press Release issued by the Company on August 16, 2010: “eLong Reports Second Quarter 2010 Unaudited Financial Results” DATED: August 17, 2010 ELONG, INC Mike Doyle Chief Financial Officer eLong Reports Second Quarter 2010 Unaudited Financial Results BEIJING, China — August 16, 2010 — eLong, Inc. (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited]

By | 2016-03-02T12:24:02+00:00 August 17th, 2010|Categories: Chinese Stocks, LONG, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, INC. SECOND QUARTER REVENUE INCREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 - Q2 2010 revenue increased 46.4% to $19.4 million - Q2 2010 Non-GAAP adjusted net income increased 50.9% to $5.8 million with adjusted EPS of $0.21 - Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and net income]

By | 2016-03-03T14:09:01+00:00 August 17th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. SECOND QUARTER REVENUE INCREASED 46.4%

[BIOSTAR PHARMACEUTICALS, INC. SECOND QUARTER REVENUE INCREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 - Q2 2010 revenue increased 46.4% to $19.4 million - Q2 2010 Non-GAAP adjusted net income increased 50.9% to $5.8 million with adjusted EPS of $0.21 - Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and net income]

By | 2016-03-03T14:10:24+00:00 August 17th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

LONG [eLong,] 6-K: 99.1 Press Release issued by thempany on August16,

[99.1 Press Release issued by thempany on August16, 2010: eLong Reports Second Quarter 2010 Unaudited Financial ResultsTED: August 17, 2010 ELONG, Mike Doyle Chief Financial Officer eLong Reports Second Quarter 2010 Unaudited Financial Results BEIJING, China August16, 2010 eLong, (Nasdaq: LONG), a leading online travel service provider in China, today reported unaudited financial results for]

By | 2016-02-07T01:53:11+00:00 August 17th, 2010|Categories: Chinese Stocks, LONG, Webplus ver|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited Second Quarter 2010 Financial Results - Conference call scheduled for Monday, August 16, 2010 at 8:00 AM EDT — Beijing — August 16, 2010 — Sinovac Biotech Ltd. ( NASDAQ: SVA), a leading China-based vaccine manufacturer , announced today its un audited financial results for the three-month and six-month periods ended June 30, 2010. Financial Highlights ·] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]

By | 2016-03-24T02:45:23+00:00 August 17th, 2010|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, SECOND QUARTER REVENUEREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 - Q2 2010 revenuereased 46.4% to $19.4 million - Q2 2010 Non-GAAPjusted netomereased 50.9% to $5.8 million withjusted EPS of $0.21 - Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and netome between $18.0 to]

By | 2016-02-07T16:54:40+00:00 August 17th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited Second Quarter 2010 Financial Results

[Sinovac Reports Unaudited Second Quarter 2010 Financial Results - Conference call scheduled for Monday, August 16, 2010 at 8:00 AM EDT — Beijing — August 16, 2010 — Sinovac Biotech Ltd. ( NASDAQ: SVA), a leading China-based vaccine manufacturer , announced today its un audited financial results for the three-month and six-month periods ended June 30, 2010. Financial Highlights ·] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]

By | 2016-03-24T02:46:18+00:00 August 17th, 2010|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, SECOND QUARTER REVENUEREASED 46.4% TO $19.4

[BIOSTAR PHARMACEUTICALS, SECOND QUARTER REVENUEREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 - Q2 2010 revenuereased 46.4% to $19.4 million - Q2 2010 Non-GAAPjusted netomereased 50.9% to $5.8 million withjusted EPS of $0.21 - Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and netome between $18.0 to]

By | 2016-02-07T16:55:13+00:00 August 17th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar